Cargando…

Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles

Extracellular vesicles (EV) can carry proteins, RNA and DNA, thus serving as communication tools between cells. Tumor cells secrete EV, which can be taken up by surrounding cells in the tumor microenvironment as well as by cells in distant organs. Tumor-derived EV (TEV) contain factors induced by tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arkhypov, Ihor, Lasser, Samantha, Petrova, Vera, Weber, Rebekka, Groth, Christopher, Utikal, Jochen, Altevogt, Peter, Umansky, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504548/ https://www.ncbi.nlm.nih.gov/pubmed/32878277 http://dx.doi.org/10.3390/ijms21176319

Ejemplares similares

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression
por: Groth, Christopher, et al.
Publicado: (2021)

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
por: Ozbay Kurt, Feyza Gul, et al.
Publicado: (2023)

HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
por: Arkhypov, Ihor, et al.
Publicado: (2022)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
por: Fleming, Viktor, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
por: Weber, Rebekka, et al.
Publicado: (2018)

Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients
por: Petrova, Vera, et al.
Publicado: (2023)

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
por: Lepper, Alisa, et al.
Publicado: (2023)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
por: Weber, Rebekka, et al.
Publicado: (2020)

HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma
por: Hüser, Laura, et al.
Publicado: (2020)

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
por: Umansky, Viktor, et al.
Publicado: (2016)

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
por: Bitsch, Rebekka, et al.
Publicado: (2022)

Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment
por: Ridder, Kirsten, et al.
Publicado: (2015)

Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
por: Shevchenko, Ivan, et al.
Publicado: (2020)

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies
por: Hüser, Laura, et al.
Publicado: (2019)

Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors
por: Simon, Sonja C. S., et al.
Publicado: (2020)

Leukocyte Count Restoration Under Dabrafenib Treatment in a Melanoma Patient With Vemurafenib-Induced Leukopenia: Case Report
por: Orouji, Elias, et al.
Publicado: (2014)

Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies?
por: Tolle, Fabrice, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells Interact with Tumors in Terms of Myelopoiesis, Tumorigenesis and Immunosuppression: Thick as Thieves
por: Sevko, Alexandra, et al.
Publicado: (2012)

Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles
por: Park, Kyong-Su, et al.
Publicado: (2019)

Extracellular Vesicles in Myeloid Neoplasms
por: Karantanou, Christina, et al.
Publicado: (2022)

Neuron-Derived Extracellular Vesicles Modulate Microglia Activation and Function
por: Peng, Hui, et al.
Publicado: (2021)

Tetraspanins distinguish separate extracellular vesicle subpopulations in human serum and plasma – Contributions of platelet extracellular vesicles in plasma samples
por: Karimi, Nasibeh, et al.
Publicado: (2022)

The International Society for Extracellular Vesicles launches the first massive open online course on extracellular vesicles
por: Lässer, Cecilia, et al.
Publicado: (2016)

T2 and T17 cytokines alter the cargo and function of airway epithelium-derived extracellular vesicles
por: Ax, Elisabeth, et al.
Publicado: (2020)

Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy
por: Park, Kyong‐Su, et al.
Publicado: (2021)

Loss of tumorigenic potential upon transdifferentiation from keratinocytic into melanocytic lineage
por: Fehrenbach, Sabrina, et al.
Publicado: (2016)

Secretogranin II influences the assembly and function of MHC class I in melanoma
por: Steinfass, Tamara, et al.
Publicado: (2023)

Stem Cell-Derived Extracellular Vesicles and Immune-Modulation
por: Burrello, Jacopo, et al.
Publicado: (2016)

The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles
por: Cvjetkovic, Aleksander, et al.
Publicado: (2014)

Myeloid Responses to Extracellular Vesicles in Health and Disease
por: Makhijani, Priya, et al.
Publicado: (2022)

Tumor-Derived Factors Differentially Affect the Recruitment and Plasticity of Neutrophils
por: Arpinati, Ludovica, et al.
Publicado: (2021)

Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response
por: Bernhardt, Mathias, et al.
Publicado: (2017)

Quantitative Proteomics Identifies Proteins Enriched in Large and Small Extracellular Vesicles
por: Lischnig, Anna, et al.
Publicado: (2022)

Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures
por: Gomes, Joana, et al.
Publicado: (2015)

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma
por: Federico, Aniello, et al.
Publicado: (2020)

Myeloid Extracellular Vesicles: Messengers from the Demented Brain
por: Nigro, Annamaria, et al.
Publicado: (2016)

Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles
por: Binder, Heide-Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7f1i60mfbhkp9b2nrok5a8553r